hims semaglutide california A & Hers commercial promoting compounded weight loss drugs in this year’s Super Bowl is spurring concerns from industry watchers over how the FDA regulates the gray area of advertising copycat Ozempic: Hims offers Apotex's generic

Struggling with weight loss despite your best efforts

Comprehensive initial consultations include hormone panels, metabolic markers, and health history review

The global GLP-1 market, estimated at $53.46 billion in 2024 and projected to reach $156.71 billion by 2030, is largely controlled by Novo Nordisk and Eli Lilly, holding over 80% of the market

Most users experience peak nausea within the first 12 weeks after starting or increasing their dose, with gradual improvement over the following 23 weeks as their body adjusts

Analyte recovery in LC-MS/MS bioanalysis: An old issue revisited [J].Analytica chimica acta, 2022(1198- ):1198.DOI:10.1016/j.aca.2022.339512